- Home
- SN vs MDGL Comparison
SN vs MDGL Comparison
Compare SN & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SN | MDGL |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 12.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SN | MDGL |
|---|---|---|
| Price | $114.91 | $585.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $132.13 | ★ $580.77 |
| AVG Volume (30 Days) | ★ 1.7M | 339.7K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.74 | N/A |
| EPS | ★ 4.05 | N/A |
| Revenue | ★ $6,084,941,000.00 | $740,640,000.00 |
| Revenue This Year | $18.94 | $436.04 |
| Revenue Next Year | $11.59 | $53.17 |
| P/E Ratio | $28.46 | ★ N/A |
| Revenue Growth | 18.87 | ★ 864.21 |
| 52 Week Low | $60.50 | $265.00 |
| 52 Week High | $128.51 | $605.00 |
Technical Indicators
Market Signals| Indicator | SN | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 72.50 | 61.71 |
| Support Level | $112.03 | $535.33 |
| Resistance Level | $115.38 | $561.00 |
| Average True Range (ATR) | 3.37 | 21.61 |
| MACD | 0.60 | -5.43 |
| Stochastic Oscillator | 95.11 | 78.31 |
Price Performance
Historical ComparisonAbout SN SharkNinja Inc.
SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.